Revlimid (Lenalidomide) Price by US State (2026 Analysis)
Estimated Revlimid (Lenalidomide) retail and out-of-pocket cost (per month supply) across all 50 US states, compared with international pharmaceutical benchmarks in India (approx. $200). US state figures represent modeled healthcare-cost adjustments from the national baseline ($16,000).
Your estimate
Revlimid (Lenalidomide) cost where you live
Pick your state to see local revlimid (lenalidomide) pricing
Compared against about $200 per month supply in India.
US figures are modeled from state medical-cost indices, not quotes from named clinics. How we estimate prices.
Every state, side by side
Sort by local price or savings, or filter to jump straight to your state.
51 of 51 states
| India | |||
|---|---|---|---|
| Alabama | $14,400 | $200 | $14,200 (99%) |
| Alaska | $20,480 | $200 | $20,280 (99%) |
| Arizona | $16,000 | $200 | $15,800 (99%) |
| Arkansas | $14,080 | $200 | $13,880 (99%) |
| California | $20,800 | $200 | $20,600 (99%) |
| Colorado | $17,280 | $200 | $17,080 (99%) |
| Connecticut | $19,520 | $200 | $19,320 (99%) |
| Delaware | $16,800 | $200 | $16,600 (99%) |
| Florida | $16,320 | $200 | $16,120 (99%) |
| Georgia | $15,360 | $200 | $15,160 (99%) |
| Hawaii | $21,120 | $200 | $20,920 (99%) |
| Idaho | $15,200 | $200 | $15,000 (99%) |
| Illinois | $16,960 | $200 | $16,760 (99%) |
| Indiana | $15,200 | $200 | $15,000 (99%) |
| Iowa | $14,880 | $200 | $14,680 (99%) |
| Kansas | $14,720 | $200 | $14,520 (99%) |
| Kentucky | $14,400 | $200 | $14,200 (99%) |
| Louisiana | $14,880 | $200 | $14,680 (99%) |
| Maine | $16,960 | $200 | $16,760 (99%) |
| Maryland | $18,880 | $200 | $18,680 (99%) |
| Massachusetts | $20,480 | $200 | $20,280 (99%) |
| Michigan | $15,680 | $200 | $15,480 (99%) |
| Minnesota | $16,960 | $200 | $16,760 (99%) |
| Mississippi | $13,760 | $200 | $13,560 (99%) |
| Missouri | $14,720 | $200 | $14,520 (99%) |
| Montana | $15,680 | $200 | $15,480 (99%) |
| Nebraska | $15,040 | $200 | $14,840 (99%) |
| Nevada | $16,320 | $200 | $16,120 (99%) |
| New Hampshire | $17,920 | $200 | $17,720 (99%) |
| New Jersey | $19,520 | $200 | $19,320 (99%) |
| New Mexico | $15,040 | $200 | $14,840 (99%) |
| New York | $20,800 | $200 | $20,600 (99%) |
| North Carolina | $15,360 | $200 | $15,160 (99%) |
| North Dakota | $15,520 | $200 | $15,320 (99%) |
| Ohio | $15,360 | $200 | $15,160 (99%) |
| Oklahoma | $14,240 | $200 | $14,040 (99%) |
| Oregon | $17,600 | $200 | $17,400 (99%) |
| Pennsylvania | $16,640 | $200 | $16,440 (99%) |
| Rhode Island | $18,240 | $200 | $18,040 (99%) |
| South Carolina | $15,200 | $200 | $15,000 (99%) |
| South Dakota | $15,200 | $200 | $15,000 (99%) |
| Tennessee | $14,720 | $200 | $14,520 (99%) |
| Texas | $16,000 | $200 | $15,800 (99%) |
| Utah | $16,000 | $200 | $15,800 (99%) |
| Vermont | $17,920 | $200 | $17,720 (99%) |
| Virginia | $16,960 | $200 | $16,760 (99%) |
| Washington | $18,880 | $200 | $18,680 (99%) |
| Washington, D.C. | $21,440 | $200 | $21,240 (99%) |
| West Virginia | $14,400 | $200 | $14,200 (99%) |
| Wisconsin | $16,000 | $200 | $15,800 (99%) |
| Wyoming | $15,680 | $200 | $15,480 (99%) |
Frequently Asked Questions: Revlimid (Lenalidomide) Pricing
Why do Revlimid (Lenalidomide) prices differ across US states?+
Prescription drug prices in the US vary by state due to differing pharmacy dispensing fee regulations, state tax laws, regional wholesale distribution costs, and varying health insurance plan coverage formularies. Out-of-pocket prices can differ by hundreds of dollars even between neighboring states.
How does the US price of Revlimid (Lenalidomide) compare to international prices?+
In the United States, Revlimid (Lenalidomide) averages approximately $16,000 per month supply. In India, certified manufacturers produce equivalent formulations and authorized generics for about $200 per month supply — saving patients up to 90%+ without compromising therapeutic equivalence.
Are generic or biosimilar versions of Revlimid (Lenalidomide) available?+
Depending on patent expiry schedules, authorized generic alternatives and international equivalents may be accessible through licensed personal importation channels.
Other Cancer Medications
Gleevec (Imatinib)
Gleevec (imatinib) is a pioneering oral targeted therapy (a tyrosine kinase inhibitor) used to treat chronic myeloid leukemia and gastrointestinal stromal tumors. It transformed certain cancers into manageable chronic conditions. India was central to making low-cost generic imatinib widely available, and a month's supply there costs a tiny fraction of the US branded price.
Keytruda (Pembrolizumab)
Keytruda (pembrolizumab) is an immunotherapy (a PD-1 checkpoint inhibitor) delivered by IV infusion that helps the immune system recognize and attack many cancers, including melanoma, lung, and head-and-neck cancers. Each dose in the USA costs many thousands of dollars and treatment runs for months. The same infusions are administered in Indian oncology centers at a substantially lower per-dose price.